Announcement on the Completion of National (Excluding Hong Kong, Macao, and Taiwan) Market Access for the Company’s 9-Valent HPV Vaccine
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment